Premarket Decliner
FDMT 4D Molecular Therapeutics11.90-1.60-11.9%
Premarket:11.48-0.42 (-3.5%)
4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference
Globe NewswireMon, 23-Sep 8:00 AM
FDMT 4D Molecular Therapeutics17.04-9.71 (-36.3%)
FDMT 4D Molecular Therapeutics21.58+0.59 (+2.8%)
FDMT 4D Molecular Therapeutics26.80-1.44 (-5.1%)